CS logo
small CS logo
Cancer Partners of Nebraska - Pine Lake

Lincoln, Nebraska, United States
Cancer treatment center in Lincoln, Nebraska
3901 Pine Lake Rd Suite 111, Lincoln, NE 68516

About Cancer Partners of Nebraska - Pine Lake


""Cancer Partners of Nebraska (formerly Southeast Nebraska Cancer Center) provides comprehensive cancer care by combining advanced medical oncology, radiation oncology and several other support services. Our goal is to provide Lincoln and Southeast Nebraska with high-quality, evidence-based cancer care in a compassionate environment.""
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Cancer Partners of Nebraska - Pine Lake


During the past decade, Cancer Partners of Nebraska - Pine Lake conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cancer Partners of Nebraska - Pine Lake" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "NRG Oncology" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Partners of Nebraska - Pine Lake" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Cancer Partners of Nebraska - Pine Lake


According to Clinical.Site data, the most researched conditions in "Cancer Partners of Nebraska - Pine Lake" are "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Stage II Lung Cancer AJCC v8" (2 trials), "Stage III Lung Cancer AJCC v8" (2 trials), "Stage IIIA Lung Cancer AJCC v8" (2 trials) and "ALK Gene Rearrangement" (1 trials). Many other conditions were trialed in "Cancer Partners of Nebraska - Pine Lake" in a lesser frequency.

Clinical Trials Intervention Types at Cancer Partners of Nebraska - Pine Lake


Most popular intervention types in "Cancer Partners of Nebraska - Pine Lake" are "Drug" (17 trials), "Biological" (13 trials), "Other" (12 trials), "Procedure" (11 trials) and "Radiation" (5 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (6 trials), "Computed Tomography" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Cancer Partners of Nebraska - Pine Lake


The vast majority of trials in "Cancer Partners of Nebraska - Pine Lake" are 17 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Cancer Partners of Nebraska - Pine Lake


Currently, there are NaN active trials in "Cancer Partners of Nebraska - Pine Lake". undefined are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer Partners of Nebraska - Pine Lake, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Partners of Nebraska - Pine Lake, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".